Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jane E. Pettinga"'
Autor:
Carrie R. Graveel, George F. Vande Woude, Marianne K. Melnik, Jane E. Pettinga, Jayne E. Paulson, Leon D. Oostendorp, Colleen A. App, Bree D. Berghuis, Erik S. Linklater, Amanda K. Paulson
Breast cancer displays significant intratumoral heterogeneity, which has been shown to have a substantial impact on both innate and acquired resistance to tyrosine kinase inhibitors. The heterogeneous expression of multiple receptor tyrosine kinases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed6e182925365d03a02914afa5a2e7f
https://doi.org/10.1158/1541-7786.c.6539575
https://doi.org/10.1158/1541-7786.c.6539575
Autor:
Carrie R. Graveel, George F. Vande Woude, Marianne K. Melnik, Jane E. Pettinga, Jayne E. Paulson, Leon D. Oostendorp, Colleen A. App, Bree D. Berghuis, Erik S. Linklater, Amanda K. Paulson
PDF - 39K, The ER, PR, and HER2 (ERBB2) status was determined by standardized immunohistochemical staining and pathological analysis at Spectrum Health. ER, PR, and HER2 scores are based on IHC guidelines recommended by the ASCO/CAP.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012d06ebd6d3bd81dcf86a726ae1ad8f
https://doi.org/10.1158/1541-7786.22510324
https://doi.org/10.1158/1541-7786.22510324
Autor:
Bree Berghuis, Amanda K. Paulson, Leon D Oostendorp, Jayne Paulson, Jane E. Pettinga, Colleen A App, Carrie R. Graveel, Marianne Melnik, George F. Vande Woude, Erik S. Linklater
Publikováno v:
Molecular Cancer Research. 11:1112-1121
Breast cancer displays significant intratumoral heterogeneity, which has been shown to have a substantial impact on both innate and acquired resistance to tyrosine kinase inhibitors. The heterogeneous expression of multiple receptor tyrosine kinases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4fbf38fb0a59fb365715bb36cedbec0
https://doi.org/10.1158/1541-7786.mcr-13-0042
https://doi.org/10.1158/1541-7786.mcr-13-0042
Autor:
Sandra J. Victor, Eric M. Horwitz, Pamela Benitez, Jane E. Pettinga, Douglas M. Brown, Vijay R. Kini, Peter Y. Chen, F.A.C.R. Alvaro Martinez M.D., Kenneth W. Shaheen, Frank A. Vicini
Publikováno v:
Cancer. 82:1303-1309
BACKGROUND. Analyses were performed to determine local control and cosmetic outcome of breast carcinoma patients with prosthetically augmented or reconstructed breasts who had received radiation therapy (RT). METHODS. Twenty-one newly diagnosed breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b29745dff2984e93b23a4c5797a40b2
https://doi.org/10.1002/(sici)1097-0142(19980401)82:7<1303::aid-cncr13>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19980401)82:7<1303::aid-cncr13>3.0.co
Autor:
David Share, Jane C. Weeks, Michael J. Hassett, Joyce C. Niland, Stephen B. Edge, Jane E. Pettinga, P. Kelly Marcom, Jonathan L. Vandergrift, James G. Herman, Richard L. Theriault, Clifford A. Hudis, Melissa E. Hughes, Yu-Ning Wong, Douglas W. Blayney, Samuel M. Silver
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(18)
Purpose Gene expression profile (GEP) testing is a relatively new technology that offers the potential of personalized medicine to patients, yet little is known about its adoption into routine practice. One of the first commercially available GEP tes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::229123b28598c06f8868650a4d638954
https://pubmed.ncbi.nlm.nih.gov/22585700
https://pubmed.ncbi.nlm.nih.gov/22585700
Autor:
Tara M. Breslin, G. K. Parish, C. A. Wesen, Jane E. Pettinga, D. Share, D. R. Smith, F. T. Pleban, J. Caughran, H. Yin, Ann M. Mehringer, T. A. Bacon-Baguley, J. L. Kreinbrink, A. T. Davis, Samuel M. Silver
Publikováno v:
Journal of Clinical Oncology. 29:1-1
1 Background: The U.S. Preventative Services Task Force (USPSTF) revised their breast cancer screening recommendations in 2009 changing their stance on age and frequency of mammography screening to biannual exams starting at age 50. The purpose of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1887e5f43b94564577014532eb819101
https://doi.org/10.1200/jco.2011.29.27_suppl.1
https://doi.org/10.1200/jco.2011.29.27_suppl.1
Autor:
Ann M. Mehringer, D. Share, Douglas W. Blayney, Jane E. Pettinga, Jonathan L. Vandergrift, A. Hayes, Haythem Ali, James G. Herman, J. Caughran, Samuel M. Silver
Publikováno v:
Journal of Clinical Oncology. 28:6039-6039
6039 Background: A 21-gene RT-PCR assay (the assay) has been recommended to predict the risk of recurrence and likelihood of adjuvant chemotherapy (AC) benefit in a subgroup of newly diagnosed pati...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb66c060fd71f78f232c5511a7bf80e
https://doi.org/10.1200/jco.2010.28.15_suppl.6039
https://doi.org/10.1200/jco.2010.28.15_suppl.6039